Sepsis 2.5

In the old days, you walked into a patient’s room, visually surveyed them, and exclaimed, “(Spicy expletive deleted!) This patient is septic!” and then you rushed out to start aggressive treatment and transfer to the intensive care unit. The reason the pundits tried to specify what constituted sepsis in the 1990s was to avoid missing cases and incurring deaths.

The problem that we have with sepsis right now is that all the attempts to codify and operationalize it left out the most important characteristic. The patient is sick. I don’t mean sick like with a cold or a stomachache; I mean SICK, in all-caps.

I believe sepsis is part of the progression of non-self-limited untreated infections. It doesn’t happen with an adenoviral upper respiratory infection. It also isn’t present in every elderly patient with cystitis.

Sepsis is the penultimate stop prior to dying from an infection. When I used to present at mortality conferences, if I saw a patient who died from an infection, but sepsis was never recognized or explicitly documented, I referred the case to quality for education of the clinical personnel.

But how to recognize it? The general criteria of the systemic inflammatory response syndrome (SIRS) of fever/hypothermia, tachycardia, tachypnea, and abnormal white blood cell count was a start. These were a cue that something was amiss, but they were too nonspecific. Zillions of conditions could result in abnormal vital signs or an abnormal white blood cell count.

“Life-threatening organ dysfunction caused by dysregulated host response to infection” was closer. In writing this, I realized the problem is in the construction of this phrase. The organ dysfunction doesn’t really have to be immediately life-threatening. The condition of sepsis is what is life-threatening; we recognize it is present by the organ dysfunction it has caused.

Howard Rodenberg et al. published an article called, “Sepsis-2.5: Resolving Conflicts Between Payers and Providers,” on behalf of the Society of Critical Care Medicine. Putting aside the fact that I wish they had invited me to be a co-author, because I have been preaching what they wrote for a long time now, I really like their no-nonsense conceptual definition of sepsis:

Sepsis is present when a patient with infection exhibits evidence of organ dysfunction at a site external to the seat of infection, or more than what is routinely expected from a localized infection.

Septic shock is present when a patient with sepsis exhibits persistent hypotension following initial fluid resuscitation.

I used to say that sepsis is when a patient is sicker than the average patient with that underlying infection, heralded by organ dysfunction. A colleague disagreed with the sicker-than-average characterization – he pointed out that if a patient is in the ICU, an intensivist might not have the same definition of “sicker than average,” because the intensivist’s patients are all sick. I mean sicker than all others with that same underlying infection of pneumonia or cellulitis or UTI, not only in the cohort of patients for whom you are caring personally.

They propose that sepsis is identified by “an ill-appearing patient, documented or suspected infection, and evidence of organ dysfunction.” I like it!

I am not sure where some of the specific guidelines stem from (e.g., hyperlactatemia being > 3.0 mmol/L); had I been a co-author, I would not have set strict criteria. Hypoxia may be sufficient; does it have to meet the threshold of acute hypoxic respiratory failure? I would not endorse a specific change from the baseline. If someone normally has platelets of 120,000 and they have thrombocytopenia of 70,000 in the proper setting, I don’t think it is reasonable to reject that as clinically significant thrombocytopenia because the decrease from baseline is less than 50 percent.

I don’t want providers to have to tick off checkboxes and grab their calculator to see if a patient qualifies. I know this was crafted with payor input, but not all payers play by the same rules. I always think that a competent provider using sound clinical judgment should be able to make a diagnosis without being pigeonholed into a specific level or change from a baseline.

Their conceptual definition does explicitly resolve the issue of organ dysfunction involving the infected system. It says “or more than what is routinely expected from a localized infection.” Acute hypoxic respiratory failure is not routinely expected in pneumonia. Acute kidney injury is not typical for urinary tract infection.

The other thing that doesn’t sit well with me is the name. I don’t like “Sepsis-2” or “Sepsis-3” or “Sepsis-2.5.” That implies that the condition of sepsis has been changing and evolving. It has not! Sepsis has always been and will continue to be a real medical condition. The only thing changing is the words we use to describe and characterize the condition.

How about “life-threatening progression of infection identified by causing organ dysfunction?” I propose we don’t give clinicians more hoops to jump through making sure the patient meets specific thresholds and rigid criteria, but let’s allow providers to make the diagnosis and treat the patient, aggressively and with alacrity.

Is this Sepsis-3.1?

Should it be?

Facebook
Twitter
LinkedIn

Erica Remer, MD, FACEP, CCDS, ACPA-C

Erica Remer, MD, FACEP, CCDS, ACPA-C has a unique perspective as a practicing emergency physician for 25 years, with extensive coding, CDI, and ICD-10 expertise. As physician advisor for University Hospitals Health System in Cleveland, Ohio for four years, she trained 2,700 providers in ICD-10, closed hundreds of queries, fought numerous DRG clinical determination and medical necessity denials, and educated CDI specialists and healthcare providers with engaging, case-based presentations. She transitioned to independent consulting in July 2016. Dr. Remer is a member of the ICD10monitor editorial board and is the co-host on the popular Talk Ten Tuesdays weekly, live Internet radio broadcasts.

Related Stories

The Enigma of Sepsis

The Enigma of Sepsis

Sepsis is one of the most (if not the most) challenging concepts in the International Classification of Diseases, 10th Edition, Clinical Modification (ICD-10-CM), the Health Insurance Portability and Accountability

Read More
Key Takeaways from CHIACON 2025

Key Takeaways from CHIACON 2025

I had the pleasure of attending the annual California Health Information Conference in Long Beach, California, as an attendee and as a speaker, last week.

Read More

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

2026 IPPS Masterclass 3: Master MS-DRG Shifts and NTAPs

2026 IPPS Masterclass Day 3: MS-DRG Shifts and NTAPs

This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 14, 2025
2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

This second session in our 2026 IPPS Masterclass will feature a review the FY26 changes to ICD-10-PCS codes. This information will be presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 13, 2025
2026 IPPS Masterclass 1: Master ICD-10-CM Changes

2026 IPPS Masterclass Day 1: Master ICD-10-CM Changes

This first session in our 2026 IPPS Masterclass will feature an in-depth explanation of FY26 changes to ICD-10-CM codes and guidelines, CCs/MCCs, and revisions to the MCE, presented by presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 12, 2025

Trending News

Featured Webcasts

The Two-Midnight Rule: New Challenges, Proven Strategies

The Two-Midnight Rule: New Challenges, Proven Strategies

RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.

June 19, 2025
Open Door Forum Webcast Series

Open Door Forum Webcast Series

Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.

June 11, 2025
Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Substance abuse is everywhere. It’s a complicated diagnosis with wide-ranging implications well beyond acute care. The face of addiction continues to change so it’s important to remember not just the addict but the spectrum of extended victims and the other social determinants and legal ramifications. Join John K. Hall, MD, JD, MBA, FCLM, FRCPC, for a critical Q&A on navigating substance abuse in 2025.  Register today and be a part of the conversation!

July 16, 2025

Trending News

Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more

Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24